Last 121.45 INR
Change Today -1.45 / -1.18%
Volume 193.9K
DISH On Other Exchanges
Symbol
Exchange
Natl India
As of 1:08 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

dishman pharmaceuticals & ch (DISH) Snapshot

Open
122.05
Previous Close
122.90
Day High
123.70
Day Low
120.70
52 Week High
09/22/14 - 197.00
52 Week Low
01/30/14 - 76.70
Market Cap
9.8B
Average Volume 10 Days
640.1K
EPS TTM
13.54
Shares Outstanding
80.7M
EX-Date
08/21/14
P/E TM
9.0x
Dividend
1.20
Dividend Yield
0.99%
Current Stock Chart for DISHMAN PHARMACEUTICALS & CH (DISH)

Related News

No related news articles were found.

dishman pharmaceuticals & ch (DISH) Related Businessweek News

No Related Businessweek News Found

dishman pharmaceuticals & ch (DISH) Details

Dishman Pharmaceuticals and Chemicals Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. It offers contract services, including process research and active pharmaceutical ingredients (APIs) supply to support early phase clinical trials; process development and optimization; cGMP manufacture; and commercial supply services. The company also manufactures and markets bulk drugs, intermediates, fine chemicals, quaternary ammonium compounds (Quats), and specialty chemicals. Its products include various vitamins and chemical products, such as Vitamin D, Vitamin D analogues, cholesterol, and lanolin related products; and specialty chemicals, including ammonium and phosphonium Quats, phosphoranes and wittig reagents, bulk API and intermediates, phase transfer catalysts, fine chemicals, and outsourced products for the pharmaceutical, cosmetic, and related industries. The company also offers a range of antiseptics and disinfectants, including disinfectants for surgical instrumentation, hand and body wash sanitizers and antiseptics, pre and post-operative surgical scrubs, and antimicrobial washes for healthcare and related industries. Dishman Pharmaceuticals and Chemicals Limited was incorporated in 1983 and is headquartered in Ahmedabad, India.

Founded in 1983

dishman pharmaceuticals & ch (DISH) Top Compensated Officers

Chairman, Managing Director, Chairman of Corp...
Total Annual Compensation: 61.0M
Managing Director, Whole-Time Director and Me...
Total Annual Compensation: 12.0M
Whole-Time Director
Total Annual Compensation: 12.0M
Compensation as of Fiscal Year 2014.

dishman pharmaceuticals & ch (DISH) Key Developments

Dishman Pharmaceuticals and Chemicals Ltd. Announces Change in Directorate

Dishman Pharmaceuticals and Chemicals Ltd. has informed that the Board of Directors vide circular resolution dated December 15, 2014, have approved the appointment of Mr. Subir Kumar Das as an Additional Director of the Company. Mr. S. K. Das shall hold office as an Additional Director till the upcoming Annual General Meeting of the company. Further the company has informed that, in terms of Section 175 of the Companies Act, 2013, the Board of Directors of the company, through passing of resolution by circulation, have noted and approved the resignation of Mr. Y. B. Desai, due to his preoccupation and personal commitments as all Independent Director with effect from December 13, 2014.

Stock Exchange Asks For Clarification Regarding Rumors Of Land Sale Talks By Dishman Pharmaceuticals

Dishman Pharmaceuticals and Chemicals Ltd. (BSE:532526) has been asked by stock exchange to provide clarifications on a recent news item appearing on ET Now, stating that Dishman Pharmaceuticals is in talks to sell its land in Gujarat. Dishman Pharmaceuticals said in a BSE filing, "The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Ltd with respect to news article appearing on ET NOW on December 2, 2014 titled -Dishman in talks with some investors to sell Gujarat Land. The reply is awaited."

Dishman Pharmaceuticals and Chemicals Ltd. Announces Unaudited Standalone and Consolidated Financial Results for the Second Quarter and Six Months Ended September 30, 2014

Dishman Pharmaceuticals and Chemicals Ltd. announced unaudited standalone and consolidated financial results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales on standalone basis of INR 1,093.657 million against INR 1,210.849 million a year ago. Profit from operations before other income and tax was INR 250.077 million against INR 239.198 million a year ago. Profit before tax was INR 342.792 million against INR 97.27 million a year ago. Net profit for the period was INR 253.785 million or INR 3.14 per diluted share against INR 63.512 million or INR 0.79 per diluted share a year ago. For the six months, the company reported on standalone basis net sales of INR 1,990.336 million against INR 2,109.504 million a year ago. Profit from operations before other income and tax was INR 397.969 million against INR 446.275 million a year ago. Profit before tax was INR 382.549 million against INR 100.17 million a year ago. Net profit for the period was INR 269.558 million or INR 3.34 per diluted share against INR 64.407 million or INR 0.8 per diluted share a year ago. For the quarter, the company reported on consolidated basis net sales of INR 3,923.235 million against INR 3,529.172 million a year ago. Profit from operations before other income and tax was INR 637.631 million against INR 695.943 million a year ago. Profit before tax was INR 472.928 million against INR 522.285 million a year ago. Net profit for the period was INR 333.571 million or INR 4.13 per diluted share against INR 422.778 million or INR 5.24 per diluted share a year ago. For the six months, the company reported net sales of INR 7,538.833 million against INR 6,591.612 million a year ago. Profit from operations before other income and tax was INR 1,086.219 million against INR 1,300.793 million a year ago. Profit before tax was INR 760.798 million against INR 860.55 million a year ago. Net profit for the period was INR 571.342 million or INR 7.08 per diluted share against INR 715.203 million or INR 8.86 per diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DISH:IN 121.45 INR -1.45

DISH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Divi's Laboratories Ltd 1,695 INR +22.10
Jubilant Life Sciences Ltd 122.30 INR -0.80
Piramal Enterprises Ltd 810.10 INR -1.50
Shasun Pharmaceuticals Ltd 273.75 INR +0.75
Torrent Pharmaceuticals Ltd 1,089 INR +10.30
View Industry Companies
 

Industry Analysis

DISH

Industry Average

Valuation DISH Industry Range
Price/Earnings 10.2x
Price/Sales 0.7x
Price/Book 0.8x
Price/Cash Flow 4.7x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DISHMAN PHARMACEUTICALS & CH, please visit www.dishmangroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.